Latest News and Press Releases
Want to stay updated on the latest news?
-
Dallas, Texas, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc. announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Roo System: a...
-
Bang & Olufsen rapporterer præliminære resultater for H1 2020/21 og opjusterer de finansielle forventninger for året De præliminære resultater for H1 2020/21 (Q2 2020/21) er som følger: ...
-
The preliminary results for H1 2020/21 (Q2 2020/21) are as follows: Revenue of DKK 1,155m, equivalent to 11% year-on-year growth in local currency (Q2: DKK 693m, equivalent to 11% year-on-year growth...
-
Ukiah, CA, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers, announced today its...
-
Board missteps led by non-independent Executive Chairman, Ashwath Mehra, significantly impeding GT Gold's ability to realize its full potentialProper board leadership and independent governance...
-
New York City, NY, Dec. 15, 2020 (GLOBE NEWSWIRE) -- In today’s competitive world, financial literacy is an extremely important aspect of one’s life. With the pandemic disrupting the global economy,...
-
Baltic Horizon Fondi (Fond) osaku puhasväärtus (NAV) 2020. aasta novembri lõpu seisuga on 1,2088 eurot osaku kohta. Fondi osaku puhasväärtuse muutus võrreldes eelneva kuu lõpu seisuga on +0,66%. Fondi...
-
Net asset value (NAV) of Baltic Horizon Fund (the Fund) unit at end of November 2020 amounted to EUR 1.2088 per unit. Compared to the previous month, NAV per unit increased by +0.66%. Total net asset...
-
Net asset value (NAV) of Baltic Horizon Fund (the Fund) unit at end of November 2020 amounted to EUR 1.2088 per unit. Compared to the previous month, NAV per unit increased by +0.66%. Total net asset...
-
LONDON and REDWOOD CITY, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH) (“Mereo” or “the Company”), a clinical stage biopharmaceutical company focused...